<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>ARDS (TH2) by Pauline Wong</title>
      <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr</link>
      <description>NUR5923 Respiratory Pathophysiology</description>
      <language>en-us</language>
      <pubDate>2023-03-08 00:29:16 UTC</pubDate>
      <lastBuildDate>2026-02-12 03:58:10 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>Instructions</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722977</link>
         <description><![CDATA[<ol><li>Choose a spokesperson</li><li>All students in the group are to work on all of the following questions/sections included in the Padlet</li><li>You can use diagrams/images other visual resources to explain each respiratory condition.</li><li>When we come back to the whole class, the spokesperson will feedback the groups findings, with the teams support</li></ol>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722977</guid>
      </item>
      <item>
         <title>1. Brief definition</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722978</link>
         <description><![CDATA[<div>ARDS - Acute Respiratory Distress Syndrome<br>Acute widespread inflammation that ends with destruction and damage of diffuse alveoli.<br>Can be direct injury (ie. pneumonia, pulmonary sepsis, COVID) or indirect injury (sepsis non pulmonary source, trauma, burns, TRALI)</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722978</guid>
      </item>
      <item>
         <title>2. Is it obstructive or restrictive? Why?</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722980</link>
         <description><![CDATA[<div>Restrictive<br><br>Decreased lung compliance from diffuse fibrosis</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722980</guid>
      </item>
      <item>
         <title>3. How does the condition effect lung compliance and/or airway resistance?</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722981</link>
         <description><![CDATA[<div>Decreases lung compliance.<br>Three phases: </div><ol><li>Oedematous phase: migration of neutrophils into the alveoli, releasing variety of substances ie. Proteases, gelatinases A and B and reactive nitrogen that damage the alveoli. Further damage occurs by alveolar macrophages and release of proinflammatory cytokines that amplify inflammatory response. Significant V/Q mismatch ( intrapulmonary shunt) evolves causing hypoxemia.</li><li>Proliferative phase: begins after 1-2 weeks, fibrosis and remodelling occurs. Reduced alveolar ventilation and pulmonary compliance and V/Q mismatch. Reduced compliance (stiff lungs) causes further atelectasis in mechanically ventilated pt as alveoli are damaged by increased volume and /or pressure on inspiration.</li><li>Fibrotic phase: the final phase where alveoli become fibrotic and the lung is left with emphysema - like alterations.</li></ol>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722981</guid>
      </item>
      <item>
         <title>4. Explain the role of V/Q mismatch in this condition.</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722983</link>
         <description><![CDATA[<div><br>V/Q mismatch (low V/Q ratio)- minimal alveolar ventilation with normal perfusion. Increased atelectasis/fibrotic tissues leads to intrapulmonary shunting.</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722983</guid>
      </item>
      <item>
         <title>5. How is oxygenation and ventilation affected? Eg. consider O2 content, O2 delivery, alveolar ventilation </title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722984</link>
         <description><![CDATA[<div>Ventilation is reduced by the exudate/oedema and decreased surfactant function, causes the alveolar to collapse leading to impaired diffusion of O2 across the alveolar-capillary membrane.&nbsp;<br>Low PaO2 due to increased A-a gradient<br><br></div>]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1993775518/e8c6fd3ecd8ba9230a4decd1aa55ede3/image.png" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722984</guid>
      </item>
      <item>
         <title>6. What type of respiratory failure would this condition lead to?</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722985</link>
         <description><![CDATA[<div>Mild/moderate - T1RF&nbsp;<br>Severe - T2RF</div>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722985</guid>
      </item>
      <item>
         <title>7. What are the typical ABGs and why?</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722987</link>
         <description><![CDATA[<div>Starts as a respiratory alkolosis - patient hyperventilating, as the disease progresses it will become a respiratory acidosis.<br><br>Respiratory Acidosis:&nbsp;<br>Mild/ Mod ARDS - T1RF: Low PaO2, normal PaCO2, Low pH<br>Severe ARDS - T2RF: becomes hypercapnic with high PaCO2&nbsp;<br><br>Could be a mixed acidosis depending on cause of initial insult<br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722987</guid>
      </item>
      <item>
         <title>8. What are the typical clinical manifestations/ patient assessment data? (relate these to pathophysiology concepts already described)</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722988</link>
         <description><![CDATA[<div>Increased WOB -&nbsp; V/Q mismatch (low)<br>Tachypneoa<br>Crackles - increased pulmonary oedema due to destruction of the pulmonary epithelium.<br>Decreased SpO2/ decreased PaO2 - exudate, alveoli collapse, fibrosis<br>Cough - clear the airway from debris&nbsp;<br>CXR - 'white out' appearance&nbsp;<br>Fatigue - prolonged increased WOB and potential for pulmonary HTN<br>Hypercapnia on ABG&nbsp;<br>Low p/f ratio </div>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722988</guid>
      </item>
      <item>
         <title>9. OPTIONAL: Important vocabulary (include list of key vocabulary referenced; if you do not know the term(s), look up and add a definition for the word(s))</title>
         <author>paulinewong1</author>
         <link>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722990</link>
         <description><![CDATA[<div><br><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2023-03-08 00:29:16 UTC</pubDate>
         <guid>https://padlet.com/paulinewong1/rbz3352u2j50anbr/wish/2507722990</guid>
      </item>
   </channel>
</rss>
